Vote Scores
Filings read through

Bio-Rad Laboratories, Inc.: how funds voted at the meeting of 22 Apr 2025

Ticker
BIO
Meeting
Season
year to 30 June 2025
Filers reporting
205
Ballot items
5

205 filers on Form N-PX reported votes at the Bio-Rad Laboratories, Inc. meeting of 22 Apr 2025. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Bio-Rad Laboratories, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 73.5% of the reported votes are for. 56 filers withheld from or voted against at least one nominee.

    813 vote records from 196 filers. 47 of the 196 filers that marked the item voted against management.

    • Positions of 46 fund families
    • For 34
    • Against 12
    • Against management 12
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    5 vote records from 5 filers. 1 of the 5 filers that marked the item voted against management.

  3. Item 3: Audit-related items (auditor ratification)

    405 vote records from 195 filers. 2 of the 195 filers that marked the item voted against management.

    • Positions of 46 fund families
    • For 46
  4. Item 4: Stockholder proposal requesting approval of certain executive severance arrangements.

    395 vote records from 191 filers. 122 of the 191 filers that marked the item voted against management.

    • Positions of 45 fund families
    • For 30
    • Against 15
    • Against management 30
  5. Item 5: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    1 vote record from 1 filer. 1 of the 1 filer that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Bio-Rad Laboratories, Inc., meeting of 22 Apr 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family3. Auditor4. Proposal
AllianceBernsteinForFor, against management
AllspringForFor, against management
American CenturyForAgainst
Artisan PartnersForNo report
BlackRock and iSharesForAgainst
BNY MellonForAgainst
Brighthouse FundsForFor, against management
Charles SchwabForAgainst
Columbia ThreadneedleForFor, against management
DimensionalForFor, against management
EquitableForAgainst
Federated HermesForFor, against management
FidelityForFor, against management
First TrustForFor, against management
Franklin TempletonForFor, against management
Goldman SachsForFor, against management
Guggenheim and RydexForFor, against management
Harbor FundsForFor, against management
Hartford FundsForFor, against management
InvescoForAgainst
J.P. MorganForAgainst
Jackson National fundsForAgainst
John Hancock and ManulifeForFor, against management
Lincoln FinancialForAgainst
MassMutualForFor, against management
MFSForFor, against management
Morgan Stanley, Eaton Vance and CalvertForFor, against management
NationwideForAgainst
Natixis and Loomis SaylesForFor, against management
Northern Trust and FlexSharesForFor, against management
Nuveen and TIAAForFor, against management
Pacific Life fundsForAgainst
PGIM and PrudentialForFor, against management
PIMCOForFor, against management
PrincipalForFor, against management
ProShares and ProFundsForFor, against management
SEIForFor, against management
State Street and SPDRForAgainst
T. Rowe PriceForAgainst
ThriventForFor, against management
TransamericaForFor, against management
VanEckForFor, against management
VanguardForAgainst
Victory CapitalForFor, against management
VoyaForFor, against management
WisdomTreeForAgainst

Questions

How many filers reported votes at the Bio-Rad Laboratories, Inc. meeting?
205 Form N-PX filers reported votes at the meeting of 22 Apr 2025. On say-on-pay, 1 of 5 filers that marked the item voted against management (20.0%). The filings show one separate proposal from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Bio-Rad Laboratories, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Bio-Rad Laboratories, Inc. with a meeting date within three days of 22 Apr 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .